Richard T. Williams

Panitumumab–FOLFOX4 Treatment and <i>RAS</i> Mutations in Colorectal Cancer

Jean‐Yves Douillard, Kelly S. Oliner, Salvatore Siena et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

Medicine, Oncology, Pharmacology +15

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

Luis A. Díaz, Richard T. Williams, Jian Wu et al. · Nature · 2012 · 1.7K citations · Full text

Medicine, Molecular Biology, Oncology +16

Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins

Richard T. Williams, Shehnaaz S.M. Manji, Nigel J. Parker et al. · Biochemical Journal · 2001 · 297 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases.

Mariam Dohadwala, Edgar F. DA CRUZ E SILVA, Frederick L. Hall et al. · Proceedings of the National Academy of Sciences · 1994 · 263 citations · Full text

Life Sciences, Biochemistry, Cell Biology +13

Mutant <i>KRAS</i> Codon 12 and 13 Alleles in Patients With Metastatic Colorectal Cancer: Assessment As Prognostic and Predictive Biomarkers of Response to Panitumumab

Marc Peeters, Jean‐Yves Douillard, Eric Van Cutsem et al. · Journal of Clinical Oncology · 2012 · 233 citations · Full text

Medicine, Oncology, Pharmacology +17